ALFA Finder| Value | ₹9.10 Cr |
|---|---|
| Execution period | within one month |
NSE filing, NSE: AMBEY. Summary written from the filing by ALFA Finder's alert engine.
More from Ambey Laboratories Limited
All →Ambey Laboratories Q4 FY26 Results: Net Profit ₹2 Cr, Up 122.2% QoQ
Ambey Laboratories Limited reported revenue from operations of ₹40.5 Cr and net profit of ₹2 Cr for Q4 FY26.
- Key figure
- Net profit ₹2 Cr
Ambey Laboratories Financial Results
Ambey Laboratories Limited approved its audited FY26 financial results, reporting consolidated revenue of ₹141.54 Crore. The board also reviewed fund utilization and related party disclosures.
Ambey Laboratories Other Announcement
Dhansa Labs Limited submitted its annual SDD Compliance Certificate for the financial year 2026. This confirms regulatory adherence to SEBI insider trading monitoring requirements.
Ambey Laboratories Other Announcement
Ambey Laboratories Limited will change its name to Dhansa Labs Limited and its NSE symbol to DHANSA. The change is effective from June 01, 2026.
Ambey Laboratories Capital Structure Change
Dhansa Labs Limited allotted 3,63,043 equity shares following warrant conversions, raising ₹1.67 Crore. This exercise increases the company's paid-up capital and strengthens its equity base.
- Value
- ₹1.67 Cr
Ambey Laboratories Board Meeting Date
Ambey Laboratories scheduled a board meeting on May 29, 2026, to approve audited annual financial results. The company's trading window remains closed until May 31, 2026.
Other merger & restructuring announcements
All →Zydus Lifesciences Merger & Restructuring
Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.
Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr
Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.
- Value
- ₹2.60 Cr
Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr
Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.
- Value
- ₹1.20 Cr
Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.
Kovai Medical Center and Hospital Merger & Restructuring Worth ₹0.85 Cr
Kovai Medical extended the completion deadline for the slump sale of its AHS division to a related-party trust to January 31, 2027. Cash consideration is Rs.84.54 Lakhs.
- Value
- ₹0.85 Cr
- Execution
- Completion expected by 31 January 2027